Background document on the AZD1222 vaccine against COVID-19 developed by Oxford University and AstraZeneca
Background document to the WHO Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID19 developed by Oxford University and AstraZeneca
5 March 2021
| Technical document
Overview
This background document on the AZD1222 vaccine against COVID-19 was prepared by the Working Group on COVID-19 Vaccines of the Strategic Advisory Group of Experts (SAGE) on Immunization to inform SAGE deliberations. It contains the evidence summary which was considered by SAGE and served as the foundation for the WHO Interim recommendations referenced below.
This background document was developed to inform the initial recommendation-making process. It is not updated on a regular basis. For the latest Grade and ETR tables see link below.
Related document:
WHO Team
Immunization, Vaccines and Biologicals (IVB),
Strategic Advisory Group of Experts on Immunization,
WHO Headquarters (HQ)
Number of pages
56
Reference numbers
WHO Reference Number: WHO/2019-nCoV/vaccines/SAGE_recommendation/AZD1222/background/2021.2
Copyright
